Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Timing matters with Zero Based Budgeting. This guide highlights scenarios and cues to start applying strategies for best impact in changing finances.
19,718 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
A reserves-and-resources update put Coeur Mining back in focus, with millions of ounces of gold on the books and a pr...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
The Supreme Court’s Feb. 20 decision voids the tariff program, setting up a possible $175 billion refunds wave that c...
Five stalwart Dividend Aristocrats continue to anchor retirement portfolios with rising payouts, steady cash flow, an...
Carvana's 2025 earnings outlook centers on cash flow, balance-sheet repair, and smarter growth. This guide breaks dow...
Fresh analyst calls on Tuesday cover a diverse set of names from Blackstone to Qualcomm, signaling continued caution ...
A major fund disclosed a new stake in Everus Construction Group, worth about $185 million, fueling discussion about t...
Looking for cash flow that lasts through retirement without chasing risky yields? Meet two resilient dividend stalwar...
Avantis U.S. Small Cap Value ETF relies on a profitability filter that separates it from ordinary small-cap funds, ai...
Explore ibotta (ibta) 2025 earnings projections, including revenue drivers, user growth, and profitability timelines....